ENGERIX-B 20 ug/mL
Hepatitis B Vaccine (Recombinant) · INJECTION, SUSPENSION · GlaxoSmithKline Biologicals SA
ENGERIX-B is a injection, suspension containing hepatitis b vaccine (recombinant) at 20 ug/mL, taken intramuscular. Manufactured by GlaxoSmithKline Biologicals SA.
Key Facts
- Brand Name
- ENGERIX-B
- Generic Name
- Hepatitis B Vaccine (Recombinant)
- NDC Code (Product)
58160-821- Manufacturer
- GlaxoSmithKline Biologicals SA
- Strength
- 20 ug/mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA103239
- Marketing Start
- 03/28/2007
Recall History
No Recall HistoryFrequently Asked Questions
What is ENGERIX-B used for?
ENGERIX-B contains Hepatitis B Vaccine (Recombinant). It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is ENGERIX-B a controlled substance?
ENGERIX-B is not classified as a controlled substance by the DEA.
What is the generic name for ENGERIX-B?
The generic name for ENGERIX-B is Hepatitis B Vaccine (Recombinant). There are 10 other brand versions of Hepatitis B Vaccine (Recombinant).
What is the NDC code for ENGERIX-B 20 ug/mL?
The NDC (National Drug Code) for ENGERIX-B 20 ug/mL is 58160-821, listed by GlaxoSmithKline Biologicals SA.
Other ENGERIX-B Dosages
Other Hepatitis Brands
See all →- HEPLISAV-B20 ug/.5mL83703-048
- RECOMBIVAX HB5 ug/.5mL0006-4093
- HEPLISAV-B20 ug/.5mL43528-003
- RECOMBIVAX HB5 ug/.5mL0006-4981
- RECOMBIVAX HB10 ug/mL0006-4094
- HEPLISAV-B20 ug/.5mL50090-4526
- RECOMBIVAX HB5 ug/.5mL83703-085
- RECOMBIVAX HB10 ug/mL0006-4995
- RECOMBIVAX HB10 ug/mL83703-086
- RECOMBIVAX HB40 ug/mL0006-4992
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)